A Comparison of Eleview Versus Hetastarch as Injectate for EMR

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

October 9, 2017

Primary Completion Date

January 7, 2019

Study Completion Date

January 7, 2019

Conditions
Procedural BleedingDelayed BleedingPost-Polypectomy SyndromePost Procedural Complication
Interventions
DRUG

Eleview

If a lesion in the colon is found to fit the description listed in the protocol, the subject will be randomized to Eleview or Hetastarch as the injectate solution for the procedure. The injectate solution is used, as needed, to aid in the resection of the target lesion.

DRUG

Hetastarch

If a lesion in the colon is found to fit the description listed in the protocol, the subject will be randomized to Eleview or Hetastarch as the injectate solution for the procedure. The injectate solution is used, as needed, to aid in the resection of the target lesion.

Trial Locations (1)

46202

Indiana University, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT03350217 - A Comparison of Eleview Versus Hetastarch as Injectate for EMR | Biotech Hunter | Biotech Hunter